Immune therapy in type 1 diabetes mellitus

@article{Lernmark2013ImmuneTI,
  title={Immune therapy in type 1 diabetes mellitus},
  author={{\AA}. Lernmark and H. Larsson},
  journal={Nature Reviews Endocrinology},
  year={2013},
  volume={9},
  pages={92-103}
}
  • Å. Lernmark, H. Larsson
  • Published 2013
  • Medicine
  • Nature Reviews Endocrinology
    • Type 1 diabetes mellitus (T1DM) is an autoimmune disorder directed against the β cells of the pancreatic islets. The genetic risk of the disease is linked to HLA-DQ risk alleles and unknown environmental triggers. In most countries, only 10–15% of children or young adults newly diagnosed with T1DM have a first-degree relative with the disease. Autoantibodies against insulin, GAD65, IA-2 or the ZnT8 transporter mark islet autoimmunity. These islet autoantibodies may already have developed in… CONTINUE READING
    View on Nature
    lup.lub.lu.se
    80 Citations
    Highly Influencial Citations
    2
    Background Citations
    28
    Methods Citations
    1
    80 Citations
    Citation Type

    Citation Type

    Advances in immunotherapy of type I diabetes.
    • 9
    Diabetes as autoimmune disease-Diabetes type
    Depleting T Cells in Newly Diagnosed Autoimmune (Type 1) Diabetes—Are We Getting Anywhere?
    • 2
    • PDF
    Risk Factors and Primary Prevention Trials for Type 1 Diabetes
    • 26
    • PDF
    Risk Factors and Primary Prevention Trials for Type 1
    Overcoming barriers in clinical islet transplantation: current limitations and future prospects.
    • 23
    Immunomodulators in Prophylaxis and Therapy of Type-1 Diabetes
    Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes
    • 83
    • PDF
    Islet inflammation in human type 1 diabetes mellitus
    • 45
    DiaPep277® and immune intervention for treatment of type 1 diabetes.
    • 11

    References

    SHOWING 1-10 OF 102 REFERENCES
    Autoantibodies in diabetes.
    • 151
    • PDF
    Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization
    • 73
    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
    • 202
    • PDF
    Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
    • 73
    Primary Dietary Intervention Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes
    • 174
    • PDF
    T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
    • 64
    • PDF
    Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes.
    • 57
    • PDF
    Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
    • 303
    Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    • 308
    • PDF
    Pancreatic β-Cell Function and Immune Responses to Insulin After Administration of Intranasal Insulin to Humans At Risk for Type 1 Diabetes
    • 146
    • PDF